The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance

被引：145
|
作者：
Gifford, Robert J. [1 ]
Liu, Tommy F. [1 ]
Rhee, Soo-Yon [1 ]
Kiuchi, Mark [1 ]
Hue, Stephane [2 ]
Pillay, Deenan [2 ,3 ]
Shafer, Robert W. [1 ]
机构：
[1] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA
[2] UCL, Dept Infect, London WC1E 6BT, England
[3] Hlth Protect Agcy, Ctr Infect, Colindale, England
来源：
BIOINFORMATICS | 2009年 / 25卷 / 09期
关键词：
REVERSE-TRANSCRIPTASE; EPIDEMIOLOGIC SURVEILLANCE; ANTIRETROVIRAL TREATMENT; SEQUENCE; TRANSMISSION; MUTATIONS; PROTEASE; EUROPE;
D O I：
10.1093/bioinformatics/btp134
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
The calibrated population resistance (CPR) tool is a web-accessible program for performing standardized genotypic estimation of transmitted HIV-1 drug resistance. The program is linked to the Stanford HIV drug resistance database and can additionally perform viral genotyping and algorithmic estimation of resistance to specific antiretroviral drugs.
引用
收藏
页码：1197 / 1198
页数：2
相关论文
共 50 条
  • [41] Transmitted and Acquired HIV-1 Drug Resistance from a Family: A Case Study
    Yan, Liting
    Yu, Fengting
    Zhang, Huimin
    Zhao, Hongxin
    Wang, Linghang
    Liang, Zaiyan
    Zhang, Xia
    Wu, Liang
    Liang, Hongyuan
    Yang, Siyuan
    Tang, Yunxia
    Zhang, Fujie
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 3763 - 3770
  • [42] Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance
    Rhee, Soo-Yon
    Tzou, Philip L.
    Shafer, Robert W.
    VIRUSES-BASEL, 2021, 13 (05):
  • [43] Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom
    Tostevin, A.
    White, E.
    Dunn, D.
    Croxford, S.
    Delpech, V.
    Williams, I.
    Asboe, D.
    Pozniak, A.
    Churchill, D.
    Geretti, A. M.
    Pillay, D.
    Sabin, C.
    Leigh-Brown, A.
    Smit, E.
    HIV MEDICINE, 2017, 18 (03) : 204 - 213
  • [44] Moderate prevalence of HIV-1 transmitted drug resistance mutations in southern Brazil
    Larissa Danielle Bahls
    Pedro Henrique Canezin
    Edna Maria Vissoci Reiche
    José Carlos Couto Fernandez
    José Ricardo Colleti Dias
    Vera Alice Fernandes Meneguetti
    Luis Toshio Ueda
    Dennis Armando Bertolini
    AIDS Research and Therapy, 16
  • [45] HIV-1 transmitted drug resistance in Brighton, UK, from 2014 to 2020
    Richardson, Daniel
    Fitzpatrick, Colin
    Parkes, Luke
    Roberts, Jonathan
    Mulka, Larissa
    INTERNATIONAL JOURNAL OF STD & AIDS, 2021, 32 (02) : 199 - 201
  • [46] Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance
    Tzou, Philip L.
    Rhee, Soo-Yon
    Descamps, Diane
    Clutter, Dana S.
    Hare, Bradley
    Mor, Orna
    Grude, Maxime
    Parkin, Neil
    Jordan, Michael R.
    Bertagnolio, Silvia
    Schapiro, Jonathan M.
    Harrigan, P. Richard
    Geretti, Anna Maria
    Marcelin, Anne-Genevieve
    Shafer, Robert W.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (01) : 170 - 182
  • [47] HIV-1 genotypic resistance in structured treatment interruptions
    Arnedo-Valero, M
    Pumarola, T
    REVIEWS IN MEDICAL MICROBIOLOGY, 2005, 16 (02) : 33 - 38
  • [48] The HIVdb System for HIV-1 Genotypic Resistance Interpretation
    Tang, Michele W.
    Liu, Tommy F.
    Shafer, Robert W.
    INTERVIROLOGY, 2012, 55 (02) : 98 - 101
  • [49] The changing HIV-1 genetic characteristics and transmitted drug resistance among recently infected population in Yunnan, China
    Chen, M.
    Jia, M. H.
    Ma, Y. L.
    Luo, H. B.
    Chen, H. C.
    Yang, C. J.
    Dai, J.
    Yang, L.
    Dong, L. J.
    Lu, R.
    Song, L. J.
    Han, Y.
    Lu, J. Y.
    Cheung, A. K. L.
    Chen, Z. W.
    Lu, L.
    EPIDEMIOLOGY AND INFECTION, 2018, 146 (06): : 775 - 781
  • [50] Antiretroviral drug resistance in HIV-1
    George J. Hanna
    Richard T. D’Aquila
    Current Infectious Disease Reports, 1999, 1 (3) : 289 - 297
12345